Team of imsCells

Prof John Pimanda

      
Prof Pimanda is a clinician scientist and Chair, Department of Pathology at UNSW Sydney. He is also the head of the Stem Cell Group and Director of the Adult Cancer Program at UNSW’s Lowy Cancer Research Centre. His research is focused on stem cell development and maintenance in health and disease. He is a Fellow of the Royal Australasian College of Physicians and Royal College of Pathologists of Australasia. He completed his PhD at UNSW in 2004 as a NHMRC postgraduate scholar and undertook post-doctoral research at the University of Cambridge as a NHMRC CJ Martin/RG Menzies postdoctoral research fellow between 2004-2008. He has been funded principally by the NHMRC since establishing his research laboratory at the Lowy in 2008. He has received career development awards from the Leukemia Foundation, Ramaciotti Foundation and the Sylvia and Charles Viertel Foundation and other awards include the 2013/2014 CINSW Big Data Big Impact Award and the 2013 Early Stage Innovations Award from New South Innovations.

Dr Vashe Chandrakanthan

      
Vashe Chandrakanthan is a Senior Research Fellow and Head of Stem Cell Development and Tissue Regeneration Laboratory at School of Medical Sciences, UNSW. He joined the Lowy Cancer Research Centre in 2010 to help set up a regenerative medicine program at UNSW. His work led to the discovery of a method of converting somatic cells into tissue-regenerative stem/progenitor cells (Chandrakanthan et al., PNAS 2016). Dr. Chandrakanthan’s work is underpinned by a strong foundation in developmental biology.
   

A Prof Ralph Mobbs

      
Ralph Mobbs is a Spinal Neurosurgeon at the Prince of Wales Private and Public Hospitals in Sydney, Australia. He is director of the NeuroSpineClinic, Chair of the NSURG research group and Editor-in-Chief of the Journal of Spine Surgery and is clinical Associate Professor in Neurosurgery. His clinical expertise is in the areas of spinal tumours, spinal trauma, and minimally invasive spine surgery for degenerative conditions. Over the last 15 years, he has developed new surgical fixation systems and implants, approaches and techniques in common use today.
   

Dr Qiao Qiao

      
Qiao is an entrepreneurial life science business development professional. He is part of the team establishing the Torch Innovation Precinct at UNSW Sydney. Qiao is dedicated to building long-lasting high value cooperation with external partners, biotechnology and pharmaceutical companies and sophisticated equity investors. Currently, he manages a multi- million-dollar portfolio of UNSW biomedical technology comprising treatments for oncology, cellular therapy, infectious and metabolic diseases as well as in vitro diagnostic and implantable medical devices. Qiao completed his PhD (Medicine) at UNSW and was awarded BSc (Biotech) with first class honours from the University of Adelaide.
   
Members of the stem cell and regenerative medicine laboratories 
at Lowy Cancer Research Centre, UNSW Sydney, Australia
(Photographer: Nick Cubbin)